A clinical study of a tumor-selective oncolytic adenovirus (Telomelysin) in combination with ionizing radiation for head and neck and thoracic malignant tumors - A clinical study of combination therapy with Telomelysin and radiation for malignant tumors

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 12 人开始时间: 2013年3月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•-Patient who has uncontrolled infectious disease and/or severe disease. -Patient who received chemotherapy, laser irradiation or stent placement within 3 weeks (or used nitrosourea or mitomycin C within 6 weeks). -Patient who receives non-local adrenocortical steroid therapy. -Patient who participated in clinical study of other unapproved drug within 4 weeks. -Patient who has or had (has less than 2 years after diagnosis of) other malignant tumors except for head and neck and thoracic malignant tumors. -Patient who cannot be kept or followed in this study due to mental, familial, social, geographical reasons. -Patient who has past history of autogenous or allogenic organ and tissue transplantations. -Patient who has positive result in serological test for HIV1, HIV2, HBV and HCV. -Patient who are considered inadequate by investigator.

发起方

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences